HE3286

· Harbor Therapeutics

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for HE3286, covering 2011-03-09 to 2011-06-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerance and Activity of HE3286 in Patients With Type 2 Diabetes Mellitus [Phase 2]